Demonstrates enhanced phototoxicity and significant apoptosis in folate-receptor-positive breast cancer cells using a novel nanoplatform.
Smart MSNCDs-FA@TMPyP nanoplatform for synergistic breast cancer treatment. Highlights : 333.3 mg g −1 drug loading, pH-sensitive release, and enhanced phototoxicity, leading to significant apoptosis in folate-receptor-positive breast cancer cells.
No takes yet. Share an insight, caveat, or question.
Serag et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: